[Efficacy and tolerance of the bisoprolol/hydrochlorothiazide combination in arterial hypertension].
Luna RL, Oigman W, Ramirez JA, Mion D, Batlouni M, da Rocha JC, Feitosa GS, Castro I, Chaves Júnior Hde C, God EM, Maia LN, Ortega KC, Raineri AM.
Luna RL, et al.
Arq Bras Cardiol. 1998 Oct;71(4):601-8. doi: 10.1590/s0066-782x1998001000008.
Arq Bras Cardiol. 1998.
PMID: 10347937
Clinical Trial.
Portuguese.
PURPOSE: Multicenter, open and non-controlled study to evaluated the efficacy and the tolerability of a low-dose combination of two anti-hypertensive agents: a cardioselective beta-blocker, bisoprolol (2.5 and 5.0 mg) with 6.25 mg of hydrochlorothiazide. METHODS: On …
PURPOSE: Multicenter, open and non-controlled study to evaluated the efficacy and the tolerability of a low-dose combination of two anti-hyp …